What is Perceptive Advisors?
Founded in 1999 and headquartered in New York, Perceptive Advisors operates as a premier investment management firm with a specialized mandate in the healthcare and life sciences sectors. With approximately $7 billion in assets under management, the firm bridges the gap between early-stage scientific discovery and commercial-scale enterprise deployment. Its market position is defined by a deep technical understanding of biotechnology, medical devices, and pharmaceutical development, allowing it to provide not just capital, but strategic guidance to companies navigating the complex regulatory and clinical pathways inherent in the life sciences industry.
How much funding has Perceptive Advisors raised?
Perceptive Advisors has raised a total of $130M across 1 funding round:
Stock Offering
$130M
Stock Issuance/Offering (2021): $130M, investors not publicly disclosed
Key Investors in Perceptive Advisors
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Perceptive Advisors?
Looking ahead, the recent influx of capital positions Perceptive Advisors to accelerate its deployment strategy across the healthcare ecosystem. As the firm scales its operations, the focus will likely shift toward identifying high-conviction opportunities in emerging biotech sectors that require substantial, long-term financial backing. By leveraging its extensive network and historical expertise, the firm is well-positioned to capitalize on the ongoing digital transformation of healthcare, ensuring that its portfolio companies remain at the forefront of clinical efficacy and market disruption. This strategic expansion will be critical in maintaining its competitive edge in an increasingly crowded and capital-intensive investment environment.
See full Perceptive Advisors company page
